← Leaderboards
Christian Yuzon Santa Maria
University Of California, San Francisco
$255,244
Attributed
$255,244
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $67.8K · FY2014–19$100K$75K$50K$25K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$255,244 · 1
By mechanism
F30$255,244 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Rebecca Kim$322,984
- Clarissa Jane Nobile$4,472,394
- David William Shearer$803,708
- Sarah Anne Wong$283,788
- Farzana Perwad$621,810
Others in their field
Top investigators on “Cell Survival”
- Gregory H Reaman · National Childhood Cancer Foundation$172,801,935
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Joseph B. Margolick · Johns Hopkins University$72,848,908
- Peter Scott Heeger · Case Western Reserve University$65,142,694
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$62,800,467
- C Kent Osborne · Baylor College Of Medicine$50,963,299
Research focus
Cell SurvivalAdultCellsAffectAgingAgonistAlveolar Bone LossAdverse EffectsAnimal ModelBiochemicalBoneBone InjuryBone LossBone MassBone NecrosisBone ResorptionBone StrengthAnabolismBone TissueBone TurnoverCalciumCalcium-Sensing ReceptorsCareerChronic
Grant awards (6)
Skeletal Anabolism by Simultaneously Targeting the PTH1R and CaSR$41,179
F30 · FY2019 · DE · contact PI
Skeletal Anabolism by Simultaneously Targeting the PTH1R and CaSR$26,625
F30 · FY2019 · DE · contact PI
Skeletal Anabolism by Simultaneously Targeting the PTH1R and CaSR$50,324
F30 · FY2018 · DE · contact PI
Skeletal Anabolism by Simultaneously Targeting the PTH1R and CaSR$49,844
F30 · FY2017 · DE · contact PI
Skeletal Anabolism by Simultaneously Targeting the PTH1R and CaSR$49,376
F30 · FY2016 · DE · contact PI
Skeletal Anabolism by Simultaneously Targeting the PTH1R and CaSR$37,896
F30 · FY2014 · DE · contact PI